spacer
home > pmps > spring 2002 > taming the validation process for automatic assembly in the pharmaceutical industry
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Taming the Validation Process for Automatic Assembly in the Pharmaceutical Industry

The validation process for the pharmaceutical industry makes the implementation of change a laborious process. Companies are reluctant to change systems and manufacturing processes because the validation consequences can be too severe. However, this article describes how the application of a tried and tested modular approach to pharmaceutical manufacturing can significantly reduce the headaches.

In the world of assembly automation there is no such thing as a standard system. Every application and every product is different and requires a different approach and different techniques to produce an assembly machine with the right accuracy, speed and flexibility.

For example, assembly machines using cam mechanisms are renowned for their reliability and speed. However, they can be inflexible which makes the accommodation of product variants or upgrades difficult and expensive, often requiring a complete redesign of the machine. Conversely, robots provide a very flexible approach. They can perform multiple tasks and can be easily reprogrammed to accept operational changes. However, robots cannot usually operate at the cycle times of cam-driven systems.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By William Bourn, Sales Manager at Modular Automation in the UK William Bourn is the Sales Manager for Modular Automation in Birmingham, UK. He has a degree in mechanical engineering from Sheffield University and has been with the company for 8 years.
William runs an established team of sales engineers for Modular Automation that specialises in developing practical, efficient assembly automation systems both for companies that regularly use automation and for those considering the switch from manual assembly.

spacer
William Bourn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MRN Expands Global Reach With Six New Hires

The clinical trial support organisation, which has recently developed a strategic partnership with World Courier focusing on patient-centric health solutions, has added six new professionals to its expanding team.
More info >>

White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drug’s efficacy if not applied correctly according to regulators’ interpretation.
More info >>

 
Industry Events

Drug Delivery Congress Europe

16-17 September 2015, Hotel Palace Berlin, Germany

Informa’s Drug Delivery Congress Europe combines two events under one roof, providing the opportunity to gain valuable insight into the latest approaches, formulations, technologies and systems to optimise your product portfolios.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement